The European Medicines Agencys safety committee concluded that semaglutide, the active ingredient in Ozempic, Wegovy, and Rybelsus, may rarely cause non-arteritic anterior ischemic optic neuropathy (NAION)
Existing data also suggest the remarkable potential of tryptophan-derived aryl hydrocarbon receptor agonists, indole derivatives on lumen equilibrium (Zhang et al., 2021)
However, studies suggest that cellderived GLP-1 is an important metabolic regulator
Caution: Large doses may cause mild digestive discomfort in sensitive individuals
The results revealed a slightly higher rate of psychiatric disorders, particularly insomnia, depressed mood, and nervousness, in those taking higher doses of liraglutide (2.4 mg and 3.0 mg)